135 related articles for article (PubMed ID: 3457784)
1. Pharmacokinetics of SCE-1141, a stereoisomer of cefmenoxime, in rats.
Kita Y; Itakura K; Tsuchiya K; Imada A
J Antimicrob Chemother; 1986 Feb; 17(2):205-13. PubMed ID: 3457784
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic study of cefmenoxime (SCE 1365-CMX) in healthy adults.
Fourtillan JB; Bryskier A; Mignot A; Borsa F; Humbert G
Am J Med; 1984 Dec; 77(6A):28-31. PubMed ID: 6097120
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of [14C]Cefmenoxime in normal subjects after intramuscular administration.
Machinist JM; Bopp BA; Quinn D
Antimicrob Agents Chemother; 1984 Oct; 26(4):431-5. PubMed ID: 6097162
[TBL] [Abstract][Full Text] [Related]
4. Absorption, distribution and excretion of cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin, in mice, rats, rabbits and dogs.
Tsuchiya K; Kita Y; Yamazaki I; Kondo M; Noji Y; Fugono T
J Antibiot (Tokyo); 1980 Dec; 33(12):1532-44. PubMed ID: 6941956
[TBL] [Abstract][Full Text] [Related]
5. Metabolic fate of SCE-1365, a new broad-spectrum cephalosporin, after parenteral administration to rats and dogs.
Tanayama S; Yoshida K; Adachi K; Kondo T
Antimicrob Agents Chemother; 1980 Oct; 18(4):511-8. PubMed ID: 6934706
[TBL] [Abstract][Full Text] [Related]
6. Intramuscular and intravenous pharmacokinetics of cefmenoxime, a new broad-spectrum cephalosporin, in healthy subjects.
Granneman GR; Sennello LT; Steinberg FJ; Sonders RC
Antimicrob Agents Chemother; 1982 Jan; 21(1):141-5. PubMed ID: 6282203
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic study of cefmenoxime concerning its transfer into tissues].
Washida H; Tsugaya M; Hirao N; Sakagami H; Iwase Y
Jpn J Antibiot; 1985 Jun; 38(6):1648-53. PubMed ID: 3862883
[TBL] [Abstract][Full Text] [Related]
8. Cefmenoxime pharmacokinetics in healthy volunteers and subjects with renal insufficiency and on hemodialysis.
Gambertoglio JG; Alexander DP; Barriere SL
Antimicrob Agents Chemother; 1984 Dec; 26(6):845-9. PubMed ID: 6098220
[TBL] [Abstract][Full Text] [Related]
9. [Clinical effect of cefmenoxime on cholecystitis; its clinical efficacy and tissue concentration].
Bekki E; Abe H; Sawada Y; Hashimoto I; Nakamura T; Mikami J; Kasai Y; Nakanishi M
Jpn J Antibiot; 1983 Jul; 36(7):1604-14. PubMed ID: 6317907
[TBL] [Abstract][Full Text] [Related]
10. Effect of probenecid on the pharmacokinetics of cefmenoxime.
Sennello LT; Quinn D; Rollins DE; Tolman KG; Sonders RC
Antimicrob Agents Chemother; 1983 Jun; 23(6):803-7. PubMed ID: 6311084
[TBL] [Abstract][Full Text] [Related]
11. [Concentrations of cefmenoxime and cefotiam in the bile and gallbladder tissue following intravenous administration in patients with biliary tract diseases].
Shoda Y; Matsuyama S; Takarada A; Arai M; Nagashima K; Nakano G; Nakamura T; Kamisaka K; Matsuzawa T; Yoshino T
Jpn J Antibiot; 1986 May; 39(5):1259-72. PubMed ID: 3463776
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of cefmenoxime in patients with impaired renal function and in those undergoing hemodialysis.
Konishi K
Antimicrob Agents Chemother; 1986 Dec; 30(6):901-5. PubMed ID: 3468882
[TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatographic determination of cefmenoxime (AB-50912) in human plasma and urine.
Noonan IA; Gambertoglio JG; Barriere SL; Conte JE; Lin ET
J Chromatogr; 1983 Apr; 273(2):458-63. PubMed ID: 6306028
[No Abstract] [Full Text] [Related]
14. [Clinical studies on the transference of cephem-type antibiotics into bile and gallbladder tissues with special reference to cefotiam and cefmenoxime].
Shiozaki H; Aeba S; Matsumoto H; Usui R; Totsuka S; Kusaba T; Mishima T; Hasegawa S; Iijima K; Okano A
Jpn J Antibiot; 1986 Mar; 39(3):751-60. PubMed ID: 3461175
[TBL] [Abstract][Full Text] [Related]
15. Plasma and skin blister fluid levels of cefotiam and cefmenoxime after single intramuscular application of 1 g in gonorrhea.
Korting HC
Chemotherapy; 1984; 30(5):277-82. PubMed ID: 6092005
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics of cefmenoxime in the aged subject (60 to 90 years of age) after an intravenous injection of 1 g].
Veyssier P; Bryskier A; Modai J; Boquet A; Fourtillan JB
Pathol Biol (Paris); 1986 Dec; 34(10):1081-3. PubMed ID: 3547264
[TBL] [Abstract][Full Text] [Related]
17. Cefmenoxime penetration into gallbladder bile and tissue.
Smith BR; LeFrock J; Carr BB
Antimicrob Agents Chemother; 1983 Jun; 23(6):941-3. PubMed ID: 6311092
[TBL] [Abstract][Full Text] [Related]
18. Disposition and metabolism of [14C]-haloperidol in rats.
Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
[TBL] [Abstract][Full Text] [Related]
19. [Cefmenoxime concentrations in human blood, bile and gallbladder in administration before surgery].
Tsukikawa S; Kubota S; Tanaka F; Watanabe H; Miyagawa F
Jpn J Antibiot; 1985 Aug; 38(8):2119-23. PubMed ID: 3866095
[TBL] [Abstract][Full Text] [Related]
20. Cefmenoxime pharmacokinetics in patients with renal insufficiency.
Polk RE; Sica DA; Kerkering TM; Kline BJ; Patterson PM; Baggett JW
Antimicrob Agents Chemother; 1984 Sep; 26(3):322-7. PubMed ID: 6095752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
